Open AccessEffectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain
Author(s) -
Martin Hale,
Srinivas Nalamachu,
Arif Khan,
Kutch
Publication year - 2013
Publication title -
journal of pain research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 49
ISSN - 1178-7090
DOI - 10.2147/jpr.s39980
Subject(s) - hydromorphone , medicine , tolerability , anesthesia , adverse effect , opioid , placebo , chronic pain , physical therapy , receptor , alternative medicine , pathology
To describe the efficacy and safety of hydromorphone extended-release tablets (OROS hydromorphone ER) during dose conversion and titration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom